Skip to main content
logo
Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.15
-0.10 (-0.34%)
Jul 30, 2026, 11:23 AM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Generic Drugs Segment
6.00B5.40B4.96B4.24B3.15B
Active Pharmaceutical Ingredients Segment
467.25M363.24M325.78M234.87M119.57M
Intersegment Income
-276.90M-210.22M-146.19M-86.89M-31.13M
Total
6.19B5.55B5.14B4.39B3.23B

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.24B4.76B4.45B3.88B2.81B
China
698.28M564.55M450.98M271.73M293.58M
United States
25.60M2.21M28.78M62.74M8.66M
Canada
11.15M2.14M15.50M34.97M30.29M
Thailand
45.81M29.70M54.56M39.60M23.16M
Malaysia
28.43M34.36M36.45M30.75M19.41M
Singapore
80.00M75.89M41.91M--
Other
61.76M79.11M60.80M70.10M46.47M
Total
6.19B5.55B5.14B4.39B3.23B